Novel stapled peptide nanoparticle combination prevents RSV infection, study finds
Friday, April 18, 2014 - 12:01
in Health & Medicine
A combination of advanced technologies may lead to a therapy to prevent or treat respiratory syncytial virus, a potentially lethal respiratory infection affecting infants, young children and the elderly, new research suggests. Despite a wide range of anti-RSV efforts, there are no vaccines or drugs on the market to effectively prevent or treat the infection.